138 related articles for article (PubMed ID: 34564023)
1. QNZ alleviated hepatocellular carcinoma by targeting inflammatory pathways in a rat model.
Al-Gayyar MMH; Alattar A; Alshaman R; Hamdan AM
Cytokine; 2021 Dec; 148():155710. PubMed ID: 34564023
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of blocking β-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion.
Hassan HM; El-Kannishy SMH; Alattar A; Alshaman R; Hamdan AM; Al-Gayyar MMH
Biomed Pharmacother; 2021 Mar; 135():111216. PubMed ID: 33433352
[TBL] [Abstract][Full Text] [Related]
3. Fucoidan Ameliorates Hepatocellular Carcinoma Induced in Rats: Effect on miR143 and Inflammation.
El-Far YM; Khodir AE; Emarah ZA; Ebrahim MA; Al-Gayyar MMH
Nutr Cancer; 2021; 73(8):1498-1510. PubMed ID: 32718197
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades.
Wang MJ; Huang HY; Chen WF; Chang HF; Kuo JS
J Neuroinflammation; 2010 Dec; 7():99. PubMed ID: 21194439
[TBL] [Abstract][Full Text] [Related]
5. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells.
Tsai JJ; Pan PJ; Hsu FT
Oncol Rep; 2017 Feb; 37(2):1036-1044. PubMed ID: 28000898
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of GSK3 differentially modulates NF-kappaB, CREB, AP-1 and beta-catenin signaling in hepatocytes, but fails to promote TNF-alpha-induced apoptosis.
Götschel F; Kern C; Lang S; Sparna T; Markmann C; Schwager J; McNelly S; von Weizsäcker F; Laufer S; Hecht A; Merfort I
Exp Cell Res; 2008 Apr; 314(6):1351-66. PubMed ID: 18261723
[TBL] [Abstract][Full Text] [Related]
7. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
8. Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.
Cavin LG; Venkatraman M; Factor VM; Kaur S; Schroeder I; Mercurio F; Beg AA; Thorgeirsson SS; Arsura M
Cancer Res; 2004 Oct; 64(19):7030-8. PubMed ID: 15466196
[TBL] [Abstract][Full Text] [Related]
9. Regulation of apoptotic and inflammatory signaling pathways in hepatocellular carcinoma via Caesalpinia gilliesii galactomannan.
Abdel-Megeed RM; Hamed AR; Matloub AA; Kadry MO; Abdel-Hamid AZ
Mol Cell Biochem; 2019 Jan; 451(1-2):173-184. PubMed ID: 30030776
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of diethylnitrosamine-induced hepatocellular carcinoma in a rat model by combination therapy of diacerein and gold nanoparticles: a histopathological and immunohistochemical study.
Baokbah TAS
J Histotechnol; 2023 Mar; 46(1):5-16. PubMed ID: 36214360
[TBL] [Abstract][Full Text] [Related]
11. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes.
Schwabe RF; Brenner DA
Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G204-11. PubMed ID: 12065308
[TBL] [Abstract][Full Text] [Related]
12. Selenium nanoparticles and quercetin suppress thioacetamide-induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement.
Mohamed AA; Zaghloul RA; Abdelghany AM; El Gayar AM
J Biochem Mol Toxicol; 2022 Apr; 36(4):e22989. PubMed ID: 35179263
[TBL] [Abstract][Full Text] [Related]
13. Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice.
Zhang ZJ; Yang YK; Wu WZ
J Transl Med; 2014 Feb; 12():57. PubMed ID: 24581171
[TBL] [Abstract][Full Text] [Related]
14. Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis.
Ram AK; Vairappan B; Srinivas BH
World J Gastroenterol; 2020 Dec; 26(45):7131-7152. PubMed ID: 33362373
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
Zaghloul RA; El-Shishtawy MM; El Galil KH; Ebrahim MA; Metwaly AA; Al-Gayyar MM
Eur J Pharmacol; 2015 Jan; 746():353-62. PubMed ID: 25449037
[TBL] [Abstract][Full Text] [Related]
16. Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism.
Ali N; Nguyen CB; Chandrakesan P; Wolf RF; Qu D; May R; Goretsky T; Fazili J; Barrett TA; Li M; Huycke MM; Bronze MS; Houchen CW
Sci Rep; 2020 Jun; 10(1):10578. PubMed ID: 32601309
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac inhibits tumor necrosis factor-α-induced nuclear factor-κB activation causing synergistic hepatocyte apoptosis.
Fredriksson L; Herpers B; Benedetti G; Matadin Q; Puigvert JC; de Bont H; Dragovic S; Vermeulen NP; Commandeur JN; Danen E; de Graauw M; van de Water B
Hepatology; 2011 Jun; 53(6):2027-41. PubMed ID: 21433042
[TBL] [Abstract][Full Text] [Related]
18. RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma.
Chua HH; Tsuei DJ; Lee PH; Jeng YM; Lu J; Wu JF; Su DS; Chen YH; Chien CS; Kao PC; Lee CN; Hu RH; Ni YH; Chang MH
Hepatology; 2015 Nov; 62(5):1480-96. PubMed ID: 26185016
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494
[TBL] [Abstract][Full Text] [Related]
20. Activation of β-catenin by inhibitors of glycogen synthase kinase-3 ameliorates cisplatin-induced cytotoxicity and pro-inflammatory cytokine expression in HEI-OC1 cells.
Kim SJ; Lim JY; Lee JN; Choe SK; Kim YI; Song SR; Cho M; So HS; Park R
Toxicology; 2014 Jun; 320():74-82. PubMed ID: 24560772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
